We are international
Donate
• about myeloma TEXT SIZE   
response assessment    back

RESPONSE ASSESSMENT: IS TREATMENT WORKING?"></div>
				
				
				
					<div class="defaultText" style="padding-bottom: 5px;"></div>
				</td>
				<td align="right" style="padding-top: 10px;">
			
			
			</td>

		</tr>
	</table>


	<table border="0" cellpadding="0" cellspacing="0" width="100%">
		<tr>
			<td width="85%"
				style="border-bottom: 1px solid #dfdfdf; padding: 0px;">
				<a
					href="ArticlePage.action?tabId=1&menuId=333&articleId=3473&aTab=-1&tBack=&tDisplayBack=true"
					style="text-decoration: none;">  
					<img src="/images/article_tab_text_o.gif"
						style="margin-bottom: -3px; border: 0;" />
				 </a>
			 
					<!--  if there is only 1 pdf display it directly -->
					
						 
					        <a href="/pdfs/Step6.pdf" onclick="pageTracker._trackPageview(
07.25.11

Be the first to comment

 related articles
International Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma
Eliminating the complete response penalty from myeloma response criteria
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Trudel - Identification of GSK-3 as a Primary Target of imids and Biomarker of Clinical Response using Drosophila


You might also be interested in:

International Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma

Eliminating the complete response penalty from myeloma response criteria
Blood, 2008, 5759-5760

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Trudel - Identification of GSK-3 as a Primary Target of imids and Biomarker of Clinical Response using Drosophila
Suzanne Trudel, MD
Princess Margaret Hospital
Toronto, Canada
May 3-6, 2011
Paris, France